Loading...
•
Dec 31, 2020
SI-BONE Q4 2020 Earnings Report
SI-BONE generated record quarterly revenues and demonstrated strong business momentum despite the COVID-19 pandemic.
Key Takeaways
SI-BONE, Inc. reported a 12% increase in worldwide revenue for the fourth quarter of 2020, reaching $22.1 million. The company's U.S. revenue also increased by 12% to $20.7 million. Despite the lingering effects of the COVID-19 pandemic, SI-BONE sees strong underlying momentum in its business and provides full year 2021 revenue guidance of $92 million to $94 million, or 25% to 28% growth.
Worldwide revenue of $22.1 million, a 12% increase year-over-year.
U.S. revenue of $20.7 million, a 12% increase year-over-year.
Gross margin of 90% remained consistent with the prior year.
Provided full year 2021 revenue guidance of $92 million to $94 million, representing 25% to 28% growth.
SI-BONE
SI-BONE
SI-BONE Revenue by Geographic Location
Revenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company expects total 2021 revenue of approximately $92 million to $94 million, representing growth of 25% to 28% compared to full year 2020.
Positive Outlook
- Positive trends in business
- Anticipates more normalized case scheduling
- Anticipates elective procedure levels progressing throughout the year
- Expects total 2021 revenue of approximately $92 million to $94 million
- Represents growth of 25% to 28% compared to full year 2020
Challenges Ahead
- COVID-19 has had and may continue to have an impact on business
- The impact of the COVID-19 pandemic on the Company's business has differed by geography and region
- 2021 outlook is highly sensitive to assumptions on a global recovery
- Assumes more normalized case scheduling
- Assumes elective procedure levels progressing throughout the year
Revenue & Expenses
Visualization of income flow from segment revenue to net income